Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+9.86%
-6.83%
+1.36%
-1.12%
-1.93%
AZN
Astrazeneca
$69.95
Chart
$67.3 (+3.94%)
$72.72 (-3.81%)
$72.72 (-3.81%)
$77.34 (-9.56%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.86%
-6.83%
+1.36%
-1.12%
-1.93%
AZN
Astrazeneca
Current Price
$69.95
Login to view Astrazeneca (AZN) recommendation from the last 90 days from financial news and social media.
Chart
$67.3 (+3.94%)
$72.72 (-3.81%)
$72.72 (-3.81%)
$77.34 (-9.56%)
AZN Latest Analysis
Is the Market ish or Bearish on AstraZeneca?. ) short percent of float has fallen 8.33% since its last report. The company recently reported that it has Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price ...
Today
AstraZeneca GSK shares down after Trump threatens drug import tariffs.
Wed Jun 18, 2025
AstraZeneca and CSPC partner on AI drug research.
Fri Jun 13, 2025
AstraZeneca signs research agreement with Chinas CSPC.
Fri Jun 13, 2025
AstraZeneca Inks Research Pact With Chinas CSPC Pharmaceuticals Focused On AI-Driven Research Valued Up To $5.33 Billion. On Friday ) entered a strategic research collaboration with Shijiazhuang City-based Per the agreement AstraZeneca and CSPC to discover and develop preclinical candidates for multiple targets with the potential to treat diseases across chronic indications including a preclinical small molecule oral therapy .CSPC will receive an upfront payment of $110 million and is also elig
Fri Jun 13, 2025
AstraZeneca Signs Nearly $5.3 Bln AI-enabled Research Deal With Chinas CSPC Pharma . (RTTNews) - British drug major AstraZeneca Plc. (AZN.L AZN) announced Friday that it has entered into a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Lts which is focused on AI-enabled research.
Fri Jun 13, 2025
The Zacks Analyst Blog Highlights Microsoft AstraZeneca and BlackRock Taylor Devices and Geospace Technologies. MSFT AZN and BLK lead Zacks top stock picks while TAYD and GEOS show resilience despite microcap market pressures.
Fri Jun 13, 2025
Top Stock Reports for Microsoft AstraZeneca & BlackRock. MSFT AZN and BLK earn praise in fresh Zacks reports with AI pharma pipelines and AUM growth fueling long-term outlooks.
Thu Jun 12, 2025
11 stocks hit 52-week highs rally up to 35% in a month . Despite the Sensex falling 823 points on Thursday 11 BSE 500 stocks hit 52-week highs signaling ish momentum. Notable gainers include Intellect Design Eris Lifesciences and Astrazeneca Pharma each rising sharply over the past month.
Thu Jun 12, 2025
Stocks in news: Wipro Motilal Oswal Jana SFB Force Motors Tech Mahindra . Markets opened positively building on Fridays gains. Wipros promoter sold shares worth ₹5057 crore while Motilal Oswal faced a Sebi fine. Jana SFB applied to become a universal bank. Tech Mahindras Americas President retired and Force Motors saw a CFO change as well. AstraZeneca Pharma India also announced MDs resignation.
Mon Jun 9, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
